Works matching AU Momohara, Shigeki

Results: 133
    1

    Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis.

    Published in:
    2017
    By:
    • Kumi Shidara;
    • Ayako Nakajima;
    • Eisuke Inoue;
    • Daisuke Hoshi;
    • Naoki Sugimoto;
    • Yohei Seto;
    • Eiichi Tanaka;
    • Shigeki Momohara;
    • Atsuo Taniguchi;
    • Hisashi Yamanaka;
    • Shidara, Kumi;
    • Nakajima, Ayako;
    • Inoue, Eisuke;
    • Hoshi, Daisuke;
    • Sugimoto, Naoki;
    • Seto, Yohei;
    • Tanaka, Eiichi;
    • Momohara, Shigeki;
    • Taniguchi, Atsuo;
    • Yamanaka, Hisashi
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Risk factors for wrist surgery in rheumatoid arthritis.

    Published in:
    Clinical Rheumatology, 2008, v. 27, n. 11, p. 1387, doi. 10.1007/s10067-008-0928-7
    By:
    • Momohara, Shigeki;
    • Inoue, Eisuke;
    • Ikari, Katusnori;
    • Tsukahara, So;
    • Kawamura, Koichiro;
    • Toki, Hiroe;
    • Hara, Masako;
    • Kamatani, Naoyuki;
    • Yamanaka, Hisashi;
    • Tomatsu, Taisuke
    Publication type:
    Article
    11
    12
    13
    14

    Investigation of treatment continuity, usefulness, and nocebo effect in switching from the original etanercept to its biosimilar in patients with rheumatoid arthritis: A JET observational study in Japanese clinical practice.

    Published in:
    Modern Rheumatology, 2024, v. 34, n. 2, p. 307, doi. 10.1093/mr/road027
    By:
    • Tsukasa Matsubara;
    • Kou Katayama;
    • Akira Sagawa;
    • Masaaki Yoshida;
    • Takeshi Mitsuka;
    • Keisuke Hashimoto;
    • Tomomaro Izumihara;
    • Masakazu Kondo;
    • Tomomasa Izumiyama;
    • Nobumasa Miyake;
    • Ichiro Yoshii;
    • Motohiro Oribe;
    • Shigeki Momohara;
    • Keiko Funahashi
    Publication type:
    Article
    15

    Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.

    Published in:
    Modern Rheumatology, 2024, v. 34, n. 2, p. 272, doi. 10.1093/mr/road063
    By:
    • Masataka Kuwana;
    • Naonobu Sugiyama;
    • Shigeki Momohara;
    • Tatsuya Atsumi;
    • Syuji Takei;
    • Naoto Tamura;
    • Masayoshi Harigai;
    • Takao Fujii;
    • Hiroaki Matsuno;
    • Tsutomu Takeuchi;
    • Kazuhiko Yamamoto;
    • Yoshinari Takasaki;
    • Miki Tanigawa;
    • Yutaka Endo;
    • Tomohiro Hirose;
    • Yosuke Morishima;
    • Noritoshi Yoshii;
    • Tsuneyo Mimori;
    • Michiaki Takagi
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan.

    Published in:
    Modern Rheumatology, 2017, v. 27, n. 5, p. 755, doi. 10.1080/14397595.2016.1265695
    By:
    • Tsuneyo Mimori;
    • Masayoshi Harigai;
    • Tatsuya Atsumi;
    • Takao Fujii;
    • Masataka Kuwana;
    • Hiroaki Matsuno;
    • Shigeki Momohara;
    • Syuji Takei;
    • Naoto Tamura;
    • Yoshinari Takasaki;
    • Satoshi Ikeuchi;
    • Satoru Kushimoto;
    • Takao Koike
    Publication type:
    Article
    26

    Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.

    Published in:
    Modern Rheumatology, 2017, v. 27, n. 2, p. 227, doi. 10.1080/14397595.2016.1205799
    By:
    • Eiichi Tanaka;
    • Eisuke Inoue;
    • Rei Yamaguchi;
    • Yoko Shimizu;
    • Akiko Kobayashi;
    • Naoki Sugimoto;
    • Daisuke Hoshi;
    • Kumi Shidara;
    • Eri Sato;
    • Yohei Seto;
    • Ayako Nakajima;
    • Shigeki Momohara;
    • Atsuo Taniguchi;
    • Hisashi Yamanaka
    Publication type:
    Article
    27

    Subcutaneous flexor tendon rupture in patients with rheumatoid arthritis.

    Published in:
    Modern Rheumatology, 2016, v. 26, n. 6, p. 869, doi. 10.3109/14397595.2016.1153444
    By:
    • Takuya Funahashi;
    • Taku Suzuki;
    • Takuji Iwamoto;
    • Kanae Shizu;
    • Noboru Matsumura;
    • Kensuke Ochi;
    • Katsunori Ikari;
    • Kazuki Sato;
    • Masaya Nakamura;
    • Morio Matsumoto;
    • Shigeki Momohara;
    • Katsuji Suzuki;
    • Harumoto Yamada
    Publication type:
    Article
    28
    29
    30

    A twin study of rheumatoid arthritis in the Japanese population.

    Published in:
    Modern Rheumatology, 2016, v. 26, n. 5, p. 685, doi. 10.3109/14397595.2015.1135856
    By:
    • Chikashi Terao;
    • Katsunori Ikari;
    • Shingo Nakayamada;
    • Yusuke Takahashi;
    • Ryo Yamada;
    • Koichiro Ohmura;
    • Motomu Hashimoto;
    • Moritoshi Furu;
    • Hiromu Ito;
    • Takao Fujii;
    • Shinji Yoshida;
    • Kazuyoshi Saito;
    • Atsuo Taniguchi;
    • Shigeki Momohara;
    • Hisashi Yamanaka;
    • Tsuneyo Mimori;
    • Fumihiko Matsuda
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.

    Published in:
    Modern Rheumatology, 2015, v. 25, n. 4, p. 503, doi. 10.3109/14397595.2014.1001475
    By:
    • Tanaka, Eiichi;
    • Inoue, Eisuke;
    • Hoshi, Daisuke;
    • Shimizu, Yoko;
    • Kobayashi, Akiko;
    • Sugimoto, Naoki;
    • Shidara, Kumi;
    • Sato, Eri;
    • Seto, Yohei;
    • Nakajima, Ayako;
    • Momohara, Shigeki;
    • Taniguchi, Atsuo;
    • Yamanaka, Hisashi
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50